These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 6455124
1. [Interactions of phenylbutazone and oxyphenbutazone with glymidine (author's transl)]. Held M, Scheible G. Arzneimittelforschung; 1981; 31(6):1036-8. PubMed ID: 6455124 [Abstract] [Full Text] [Related]
2. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency. Held H, Enderle C. Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326 [Abstract] [Full Text] [Related]
3. [Decreased serum protein binding of glymidine in icteric liver disease and its partial correction with charcoal (author's transl]. Held H. Klin Wochenschr; 1979 Jul 03; 57(13):693-5. PubMed ID: 158106 [Abstract] [Full Text] [Related]
4. [Effect of phenylbutazone and oxyphenbutazone on gastric acid production]. Hemmati A. Arzneimittelforschung; 1969 Jul 03; 19(7):1130-2. PubMed ID: 5394515 [No Abstract] [Full Text] [Related]
8. Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man. Hvidberg EF, Dayton PG, Read JM, Wilson CH. Proc Soc Exp Biol Med; 1968 Nov 03; 129(2):438-43. PubMed ID: 5696765 [No Abstract] [Full Text] [Related]
9. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)]. Spahn H, Mutschler E, Geissler HE, Faust-Tinnefeldt G. Arzneimittelforschung; 1981 Nov 03; 31(3):499-503. PubMed ID: 6894380 [Abstract] [Full Text] [Related]
10. [A contribution on the antiproteolytic activity quality of phenylbutazone, oxyphenbutazone and sodium salicylate]. Mörsdorf K, Marten S, Puchert I. Arzneimittelforschung; 1968 Dec 03; 18(12):1516-20. PubMed ID: 5756244 [No Abstract] [Full Text] [Related]
11. [On the thyrostatic effect of phenylbutazone and oxyphenbutazone under the influence of triiodothyronine]. Eger W, Fernholz J. Med Pharmacol Exp Int J Exp Med; 1965 Dec 03; 13(1):17-23. PubMed ID: 5898618 [No Abstract] [Full Text] [Related]
12. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone. O'Reilly RA. Ann N Y Acad Sci; 1973 Nov 26; 226():293-308. PubMed ID: 4520398 [No Abstract] [Full Text] [Related]
13. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys. Mealey KL, Matthews NS, Peck KE, Ray AC, Taylor TS. Am J Vet Res; 1997 Jan 26; 58(1):53-5. PubMed ID: 8989496 [Abstract] [Full Text] [Related]
14. The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia. Smith CS, Chinn S, Watts RW. Biochem Pharmacol; 1977 May 01; 26(9):847-52. PubMed ID: 861050 [No Abstract] [Full Text] [Related]
15. Inhibition of DNA synthesis in cultured human lymphocytes by phenylbutazone and oxyphenbutazone. Dewse CD. J Pharm Pharmacol; 1976 Jul 01; 28(7):596-8. PubMed ID: 8620 [No Abstract] [Full Text] [Related]
16. The effect of oxyphenbutazone on the excretion of 14 C-warfarin in the bile of rat. Wosilait WD, Eisenbrandt LL. Res Commun Chem Pathol Pharmacol; 1972 Sep 01; 4(2):413-20. PubMed ID: 5074533 [No Abstract] [Full Text] [Related]
17. Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems. Woods WE, Weckman T, Blake JW, Tobin T. J Pharmacol Methods; 1986 Dec 01; 16(4):297-313. PubMed ID: 3784574 [Abstract] [Full Text] [Related]
18. Inhibitory effect of phenylbutazone and oxyphenbutazone on DNA synthesis in normal human bone marrow cells in vitro. Dewse CD, Potter CG. J Pharm Pharmacol; 1975 Jul 01; 27(7):523-6. PubMed ID: 239158 [No Abstract] [Full Text] [Related]
19. [Studies on the effects of oxyphenbutazone and phenylbutazone on hepatic lysosomes]. Platt D, Schnorr B, Keudel R. Klin Wochenschr; 1972 Sep 15; 50(18):875-81. PubMed ID: 5079583 [No Abstract] [Full Text] [Related]
20. [Clinical and experimental studies on phenylbutazone and oxyphenbutazone]. Zicha L, Scheiffarth F, Schmid E, Tauber O, Finger H. Arzneimittelforschung; 1965 Aug 15; 15(8):921-3. PubMed ID: 4379385 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]